Brkt Amsterdam to host IATA annual general meeting in 2020
Underlying profit for Rolls-Royces civil aerospace division was down by more than 90%, to just 拢31 million $41 million , over the first half as revenues slipped by 5% to 拢3.2 billion.Civil aerospace counted for half of Rolls-Royce group revenues over the six-month period, but the division has been affected by price and volume reduction in Trent 700 engine activity for the Airbus A330 programme.Both original equipment and aftermarket revenues were down in the first half. Rolls-Royce delivered 312 engines compared with 326 last year.It says the transition from the A330 to the A330neo has resulted in a profitability impact in line with earlier estimates, an
stanley cup d adds that this effect has been exacerbated by the shift towards unlinked accounting in engine sales.But the company points out that it will hold an exclusive position on the A330neo through the Trent 7000 powerplant, while it stands to benefit from ramp-up of the A350 for which its Trent XWB is the sole engine.Rolls-Royce says that softening markets in the business-jet sector, and fewer overhauls of large engines on mature programmes, have contributed to the first half civil aerospace decline. It
stanley cup has also experienced higher technical costs on large engines including its Trent 1000.Large engine sales increased by 3.6%, partly lifted by Trent 900 deliveries under the Emirates A380
stanley cup contract as well as Trent XWBs for the A350 and more Trent 1000s for the Boeing 787.But service revenues for large engines were down by 6%, f Hjak Qantas veteran Yangoyan named as new Qantaslink head
WASHINGTON AP 鈥?Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD 鈥?part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug purported benefits.The Food and Drug Administration convened a panel of outside experts Tuesday to review the latest research on the drug, which appears to show it can help relieve post-traumatic stress disorder when combined with talk therapy.But FDA regulators have questions about the reliability of that data, as well as MDMA safety risks, which include the potential for heart problems, injury and drug abuse.The FDA panel will vote later Tuesday on whether to recommend the drug use for PTSD, which could set the stage for federal approval later this summer, though the FDA isn ;t required to follow the group recommendations.MDMA, sometimes called ecstasy or molly, would become the first illegal psychedelic, if approved, to make the leap to mai
stanley mugg nstream medicine. The drug is the first in a series of psy
stanley nz chedelics 鈥?including LSD and psilocybin 鈥?that are expected to come before the FDA in the next few years as part of renewed research and interest into their potential to address hard-to-treat conditions like depression, addiction and anxiety.Currently,
stanley cup only antidepressants are FDA-approved for PTSD, which is closely linked to depression, anxiety and suicidal behavior. PTSD is also more prevalent among women
